{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T17:27:18Z","timestamp":1768325238061,"version":"3.49.0"},"reference-count":76,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:00:00Z","timestamp":1535587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["11CRP5130028"],"award-info":[{"award-number":["11CRP5130028"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["5UL1TR001073"],"award-info":[{"award-number":["5UL1TR001073"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UO1\u2010AI\u201035004"],"award-info":[{"award-number":["UO1\u2010AI\u201035004"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>African women are disproportionately affected by <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> infection and may experience non\u2010<jats:styled-content style=\"fixed-case\">AIDS<\/jats:styled-content>\u2010related complications associated with inflammation. High\u2010sensitivity C\u2010reactive protein (hs<jats:styled-content style=\"fixed-case\">CRP<\/jats:styled-content>), <jats:sc>d<\/jats:sc>\u2010dimer and transthyretin have been examined as inflammatory markers elsewhere, but it is unclear how they change over time in <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010negative or <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010positive African women with or without antiretroviral therapy (<jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content>) initiation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We examined hs<jats:styled-content style=\"fixed-case\">CRP<\/jats:styled-content>,<jats:sc> d<\/jats:sc>\u2010dimer and transthyretin levels at baseline and at follow\u2010up of \u22652\u00a0years in 185 <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010negative and 510 <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010positive Rwandan women who were <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> na\u00efve at study entry. Generalized estimating equations for each marker were used to investigate the association with <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> infection\/<jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4 count, <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> and follow\u2010up time.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010negative women, <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010positive women had higher hs<jats:styled-content style=\"fixed-case\">CRP<\/jats:styled-content> and <jats:sc>d<\/jats:sc>\u2010dimer and lower transthyretin concentrations, with greater differences at lower <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4 counts. After adjusting for <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4 count and other factors, <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> was not significantly associated with log hs<jats:styled-content style=\"fixed-case\">CRP<\/jats:styled-content> (<jats:italic>P\u00a0<\/jats:italic>=\u00a00.36) at follow\u2010up, but was independently associated with lower log <jats:sc>d<\/jats:sc>\u2010dimer (<jats:italic>P\u00a0<\/jats:italic>=\u00a00.03) and higher transthyretin (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.0008) concentrations. At \u2265\u00a02\u00a0years of follow\u2010up, hs<jats:styled-content style=\"fixed-case\">CRP<\/jats:styled-content> had not significantly changed in any group but log <jats:sc>d<\/jats:sc>\u2010dimer had decreased significantly in all groups. Transthyretin declined significantly over time in <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010negative women and <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010positive non\u2010<jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> initiators, but increased significantly in <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010positive <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> initiators.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> infection and advanced immune suppression were associated with higher hs<jats:styled-content style=\"fixed-case\">CRP<\/jats:styled-content> and <jats:sc>d<\/jats:sc>\u2010dimer and lower transthyretin concentrations. <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> (independently of <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4 changes) was significantly associated with decreases in <jats:sc>d<\/jats:sc>\u2010dimer and increases in transthyretin, but, in contrast to other studies, was not associated with decreases in hs<jats:styled-content style=\"fixed-case\">CRP<\/jats:styled-content>. We found no change in hs<jats:styled-content style=\"fixed-case\">CRP<\/jats:styled-content> over time in any group.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hiv.12665","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T15:26:56Z","timestamp":1535642816000},"page":"734-744","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Longitudinal evaluation of markers of inflammation in <scp>HIV<\/scp>\u2010positive and <scp>HIV<\/scp>\u2010negative Rwandan women"],"prefix":"10.1111","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3411-1273","authenticated-orcid":false,"given":"EM","family":"Kiefer","sequence":"first","affiliation":[{"name":"Department of Internal Medicine John A. Burns School of Medicine University of Hawaii Honolulu HI USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DR","family":"Hoover","sequence":"additional","affiliation":[{"name":"Department of Statistics\/Biostatistics Institute for Health Health Care Policy and Aging Research Rutgers University Piscataway NJ USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Public Health New York Medical College Valhalla NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JC","family":"Dusingize","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Queensland Brisbane Qld Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JD","family":"Sinayobye","sequence":"additional","affiliation":[{"name":"Rwanda Military Hospital Kigali Rwanda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Anastos","sequence":"additional","affiliation":[{"name":"Department of Medicine Montefiore Medical Center Albert Einstein College of Medicine Bronx NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,8,30]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"UNAIDS.Prevention gap report 2016. Available at:http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2016-prevention-gap-report_en.pdf(accessed 2 October 2017)."},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.10.001"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181e66216"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050203"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.19.3.493"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu254"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.000844"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1086\/652749"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155100"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152588"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu175"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000237"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001095"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1042\/CS20160112"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-017-4117-y"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200302010-00014"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1086\/605447"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(99)00210-5"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.1.64"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs0860461"},{"key":"e_1_2_8_22_1","first-page":"317","article-title":"Acute phase proteins, trace elements in asymptomatic human immunodeficiency virus infection in Nigerians","volume":"33","author":"Arinola OG","year":"2004","journal-title":"Afr J Med Med Sci"},{"key":"e_1_2_8_23_1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4103\/1117-1936.181056","article-title":"Serum concentration of acute phase protein and lipid profile in HIV\u20101 seropositive patients and its relationship to the progression of the disease","volume":"15","author":"Ogunro PS","year":"2008","journal-title":"Niger Postgrad Med J"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2007.0083"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2006.09.013"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000344"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-414"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000954"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181b939e5"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir134"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044454"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833ad914"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir989"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024243"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090978"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000306"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31825b03be"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199712010-00008"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1600789"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/136.6.1624"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2009.04.005"},{"key":"e_1_2_8_42_1","unstructured":"McComseyGA SmithKY PatelPet\u00a0al.Similar reductions in markers of inflammation and endothelial activation after initiation of abacavir\/lamivudine (ABC\/3TC) or tenofovir\/emtricitabine (TDF\/FTC) in the HEAT Study.Conference on Retroviruses and Opportunistic Infections (CROI); February 8\u201011 2009;Montreal QC Canada 2009."},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283389dfa"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00193-07"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2012.0086"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.10.009"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328319807f"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833562c5"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.17.4.19551"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832995fa"},{"key":"e_1_2_8_51_1","first-page":"2434","article-title":"C\u2010Reactive protein levels over time and cardiovascular risk in HIV\u2010infected individuals suppressed on an indinavir\u2010based regimen: AIDS Clinical Trials Group 5056s","volume":"18","author":"Henry K","year":"2004","journal-title":"AIDS"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.17.4.19545"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2010.0187"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832cbcc2"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/85.1.182"},{"key":"e_1_2_8_56_1","unstructured":"ShikumaC ZhengE RibaudoHet\u00a0al.96\u2010week effects of suppressive efavirenz\u2010containing ART abacavir and sex on high\u2010sensitivity C\u2010reactive protein. 16th Conference on Retroviruses and Opportunistic Infections; February 2009;Montreal CA 2009."},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2008.00661.x"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.5.613"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2009.1367"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902113400607"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000148981.71644.C7"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-8-156"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328354f4fb"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0633"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1928"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-40"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-267"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181f7f61a"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2010.0154"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)00785-2"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04517.x"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.2174\/1876506801104010011"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199511000-00008"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000230320.78288.79"},{"key":"e_1_2_8_75_1","first-page":"359","article-title":"Association of hepatitis C with markers of hemostasis in HIV\u2010infected and uninfected women in the women's interagency HIV study (WIHS)","volume":"60","author":"Kiefer E","year":"2012","journal-title":"JAIDS"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3_suppl.338S"},{"issue":"1","key":"e_1_2_8_77_1","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1017\/S0007114507839626","article-title":"Nutritional status in patients with HIV infection and AIDS","volume":"98","author":"Stambullian M","year":"2007","journal-title":"Br J Nutr"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhiv.12665","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.12665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T00:35:32Z","timestamp":1694910932000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hiv.12665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,30]]},"references-count":76,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1111\/hiv.12665"],"URL":"https:\/\/doi.org\/10.1111\/hiv.12665","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,30]]},"assertion":[{"value":"2018-06-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}